Cardio-Oncology—Beyond Anthracyclines and Ejection Fraction - 30/05/24

Doi : 10.1016/j.hlc.2024.05.002

Paul D. Geenty, MBBS, MPhil, FRACP ^a,^b, Ann T. Gregory, MBBS, GradCertPopHealth ^c,^{^{1
Commissioning Editor, Heart, Lung and Circulation}}, Mark Nolan, MBBS, PhD, FRACP ^d,^e,^{^{2
Guest Editor, Special Issue: Cardio-Oncology, Heart, Lung and Circulation}}, A. Robert Denniss, MD, MSc, FCASANZ ^a,^c,^f,^g,^{^{2
Guest Editor, Special Issue: Cardio-Oncology, Heart, Lung and Circulation}}, Salvatore Pepe, PhD, FAHA, FCSANZ ^c,^h,^i,^{^{3
Editor-in-Chief, Heart, Lung and Circulation}}, Aaron L. Sverdlov, MBBS, PhD, FRACP ^j,^k,^⁎,^{^{2
Guest Editor, Special Issue: Cardio-Oncology, Heart, Lung and Circulation},}^{^{4
Equal Last Authors}} , Liza Thomas, MBBS, PhD, FRACP ^a,^b,^⁎,^l,^{^{2
Guest Editor, Special Issue: Cardio-Oncology, Heart, Lung and Circulation},}^{^{4
Equal Last Authors}}
^a Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia
^b Westmead Clinical School, The University of Sydney, NSW, Australia
^c Heart, Lung and Circulation, Sydney, NSW, Australia
^d Baker Heart and Diabetes Institute, Melbourne, Vic, Australia
^e Peter MacCallum Cancer Centre, Melbourne, Vic, Australia
^f The University of Sydney, Sydney, NSW, Australia
^g Department of Cardiology, Blacktown Hospital, and Western Sydney University, Sydney, NSW, Australia
^h Heart Research Group, Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne
ⁱ Department of Paediatrics, The University of Melbourne, Melbourne, Vic, Australia
^j Newcastle Centre of Excellence in Cardio-Oncology, The University of Newcastle; Hunter Medical Research Institute; Calvary Mater Newcastle, Hunter New England Health, Newcastle, NSW, Australia
^k Cardiovascular Department, John Hunter Hospital, Newcastle, NSW, Australia
^l Southwest Clinical School, University of New South Wales, NSW, Australia

^∗Corresponding author at: Professor Aaron Sverdlov, Newcastle Centre of Excellence in Cardio-Oncology, Hunter Medical Research Institute, The University of Newcastle, New Lambton Heights, NSW 2305, AustraliaNewcastle Centre of Excellence in Cardio-OncologyHunter Medical Research InstituteThe University of NewcastleNew Lambton HeightsNSW2305Australia^∗∗Corresponding author at: Professor Liza Thomas, Department of Cardiology, PO Box 533, Wentworthville, NSW 2145, AustraliaDepartment of CardiologyPO Box 533WentworthvilleNSW2145Australia

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Cardiology, Oncology, Cardiovascular disease, Cardiovascular toxicity, Risk management, Cardio-Oncology

Il testo completo di questo articolo è disponibile in PDF.

Mappa

What is Cardio-Oncology?

Cardiotoxicity—More Than Just Reduced Ejection Fraction

Conclusion

Esportazione

Vol 33 - N° 5

P. 547-552 - maggio 2024 Ritorno al numero

Articolo precedente

Editorial Board

| Articolo seguente

Cardiotoxicity in Oncology Guidelines: Discrepancies Do Matter
Sean Tan, Zainel Kader, Daphne Day, Daniel Chen, Stephen J. Nicholls, Satish Ramkumar

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

connettersi o creare un account

Cardio-Oncology—Beyond Anthracyclines and Ejection Fraction - 30/05/24

Mappa

Citazioni Export

File

Contenuto

Il mio account

Aide & support

Dichiarazione CNIL